Peptides DB
Research-centric peptide and protocol reference hub

CJC-1295 with DAC record · updated 18h ago

Muscle & body compMetabolic & appetiteGrade B · human evidenceResearch use only
All 9 studiesJump to the evidenceCompare
What is CJC-1295 with DAC used for?

CJC-1295 with DAC is a long-acting GHRH analog bound to serum albumin, studied as an investigational growth hormone secretagogue with a multi-day half-life and sustained IGF-1 elevation.

How it works: GHRH analog with drug-affinity complex (albumin-binding)

Primarily researched for · Muscle & body compRoute · Subcutaneous injection

Development stage

where CJC-1295 with DAC sits between preclinical work and regulatory approval
  1. 1Current
    Preclinical
    Animal / in-vitro work
  2. 2Not reached
    Phase 1
    Safety in humans
  3. 3Not reached
    Phase 2
    Efficacy signal
  4. 4Not reached
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus and 143 registered trials. It describes the research record, not a recommendation.

Identity
NameCJC-1295 with DAC
Chain length—
Molecular weight—
Formula—
Structure type—
ClassMuscle
Research levelPreclinical
Discovered byCurated master list · 2026
Pharmacology
MechanismGHRH analog with drug-affinity complex (albumin-binding)
RouteSubcutaneous injection
Half-life~6–8 days
Time to peak—
Duration—
Extraction confidence0.70
Effect profile · 0–5
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Oct 9, 2026. How this works →
Research stats
Total studies9
Human / animal / cellular2 / 2 / 1
Highest trial phasePreclinical
Years covered2020–2026
Latest study8d ago
Publication history
20202026
Research funding
—no NIH grants found
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work—
Community reports—
Positive —Neutral —Negative —
Records

Study register

9 rowsOpen in the library →
StudyTypeYearSummary depth
Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial.
TakeawayNot reported in abstract.
review2025Title only0.10
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC.
TakeawayNot reported in abstract.
—2026Title only0.10
Uncovering origins of heterogeneous superconductivity in La(3)Ni(2)O(7).
TakeawayNot reported in abstract.
—2026Title only0.10
Drosophila eye development is compromised by dTet overexpression through altered retinal determination gene expression.
FindingNot reported in abstract.
Animal2026Full text read0.80
Knoevenagel condensation for malonate-grafted dialdehyde cellulose: Tuning mechanical and swelling properties of poly(acrylic acid-co-itaconic acid) bio-SAPs.
FindingEquilibrium swelling capacity of 1556 ± 58 g g<sup>-1</sup> in distilled water.
In vitro2026Full text read0.80
Evaluating the nutritional and economic potential of defatted algae cake in aquaculture: A review.
FindingDAC inclusion levels generally under 10% in fish feed maintain growth performance.
review2026Full text read0.80
Engineering metal-non-metal asymmetric dual-atom catalyst for disulfidptosis-mediated potent immunotherapy.
Finding93% suppression of primary tumor growth in vivo.
Animal2026Full text read0.70
Estimation of airborne contamination during therapeutic radioiodine-131(I-131) administration: A comparative study between capsule and solution forms.
FindingMinimum airborne activity was 8.53 Bq/m³ (50 mCi of I-131 in capsule form), whereas a maximum contamination of 76.50 Bq/m³ (200 mCi of I-131 solution).
Human2026Full text read0.90
Characteristics and Attitudes of Men Using Anabolic Androgenic Steroids (AAS): A Survey of 2385 Men.
FindingAverage participant age was 31.69 ± 10.09 years.
Human2020Full text read0.90

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching CJC-1295 with DAC will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much CJC-1295 with DAC is discussed should be drawn from it.